Cargando…

Hypoxia and Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease worldwide and comprises varied grades of intrahepatic lipid accumulation, inflammation, ballooning, and fibrosis; the most severe cases result in cirrhosis and liver failure. There is extensive clinical and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isaza, Stephania C., del Pozo-Maroto, Elvira, Domínguez-Alcón, Lucía, Elbouayadi, Liliam, González-Rodríguez, Águeda, García-Monzón, Carmelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645232/ https://www.ncbi.nlm.nih.gov/pubmed/33195326 http://dx.doi.org/10.3389/fmed.2020.578001

Ejemplares similares

Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea
por: Rey, Esther, et al.
Publicado: (2020)

Hypoxia‐inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36
por: Rey, Esther, et al.
Publicado: (2020)

Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
por: Marañón, Patricia, et al.
Publicado: (2022)

Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Holzner, Lorenz M. W., et al.
Publicado: (2021)

Concerted regulation of non-alcoholic fatty liver disease progression by microRNAs in apolipoprotein E-deficient mice
por: López-Pastor, Andrea R., et al.
Publicado: (2021)

Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis
por: Marañón, Patricia, et al.
Publicado: (2023)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
por: Idalsoaga, Francisco, et al.
Publicado: (2020)

Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease
por: Funuyet-Salas, Jesús, et al.
Publicado: (2020)

Sleep apnea-COPD overlap syndrome is associated with larger left carotid atherosclerotic plaques
por: Landete, Pedro, et al.
Publicado: (2023)

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
por: Malhotra, Pooja, et al.
Publicado: (2020)

Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation
por: Barbier-Torres, Lucía, et al.
Publicado: (2020)

Knowing What’s Out There: Awareness of Non-Alcoholic Fatty Liver Disease
por: Ghevariya, Vishal, et al.
Publicado: (2014)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

Intermittent Hypoxia Rewires the Liver Transcriptome and Fires up Fatty Acids Usage for Mitochondrial Respiration
por: Gaucher, Jonathan, et al.
Publicado: (2022)

Increased Oxygen Desaturation Time During Sleep Is a Risk Factor for NASH in Patients With Obstructive Sleep Apnea: A Prospective Cohort Study
por: Landete, Pedro, et al.
Publicado: (2022)

Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
por: Delli Bovi, Anna Pia, et al.
Publicado: (2021)

The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Wongtrakul, Wasit, et al.
Publicado: (2021)

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients
por: Sugimoto, Ryosuke, et al.
Publicado: (2023)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease
por: Xiao, Jieling, et al.
Publicado: (2021)

Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update
por: Li, Na, et al.
Publicado: (2021)

Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease
por: Santacroce, Giovanni, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease and Longitudinal Cognitive Changes in Middle-Aged and Elderly Adults
por: Liu, Qi, et al.
Publicado: (2022)

Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
por: Parameswaran, Madhangi, et al.
Publicado: (2021)

Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease
por: Jose, Nijin, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease and Gallstones: A Systematic Review
por: Slouha, Ethan, et al.
Publicado: (2023)

Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
por: Rada, Patricia, et al.
Publicado: (2020)

CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver
por: Pang, Qiwen, et al.
Publicado: (2020)

Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis
por: Wang, Ting, et al.
Publicado: (2022)

Liver osteopontin is required to prevent the progression of age‐related nonalcoholic fatty liver disease
por: Gómez‐Santos, Beatriz, et al.
Publicado: (2020)

Anthropometric Measurements and Lifestyle Characteristics of Individuals with Non-alcoholic Fatty Liver Disease
por: Tahir, Faryal, et al.
Publicado: (2020)

Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease
por: Sun, Qing-Feng, et al.
Publicado: (2022)

An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease
por: Rodríguez-Sanabria, J. Samael, et al.
Publicado: (2022)

Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease
por: Amir, Muhammad, et al.
Publicado: (2020)

Effects of Telemedicine on Obese Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Saokaew, Surasak, et al.
Publicado: (2021)

Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease
por: Han, Juqiang, et al.
Publicado: (2021)

Non-alcoholic/Metabolic-Associated Fatty Liver Disease and Helicobacter pylori Additively Increase the Risk of Arterial Stiffness
por: Choi, Ji Min, et al.
Publicado: (2022)

Association between grip strength and non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Han, Liu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fc67vd6acjivvga0rqooqmqqer